General Meeting

General Meeting

The general meeting is Ascelia Pharma’s highest decision-making body. At the general meeting, the shareholders exercise their voting rights in key issues. To attend and vote at the general meeting, either in person or through a proxy, shareholders must be registered in the share register kept by Euroclear Sweden AB five business days prior to the meeting and also register their participation to Ascelia Pharma no later than on the date specified in the notice convening the meeting.

Documents related to general meetings are found in the table below.